Harvard Bioscience Operating Margin 2010-2023 | HBIO

Current and historical operating margin for Harvard Bioscience (HBIO) over the last 10 years. The current operating profit margin for Harvard Bioscience as of December 31, 2023 is 1.82%.
Harvard Bioscience Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2023-12-31 $0.11B $0.00B 1.79%
2023-09-30 $0.11B $0.00B 1.79%
2023-06-30 $0.11B $-0.00B -0.88%
2023-03-31 $0.11B $0.00B 1.75%
2022-12-31 $0.11B $-0.01B -6.19%
2022-09-30 $0.12B $-0.01B -4.24%
2022-06-30 $0.12B 0 0.00%
2022-03-31 $0.12B $-0.00B -3.31%
2021-12-31 $0.12B $0.00B 2.52%
2021-09-30 $0.12B $0.00B 3.42%
2021-06-30 $0.11B $0.00B 2.70%
2021-03-31 $0.11B $0.00B 3.81%
2020-12-31 $0.10B $0.00B 0.98%
2020-09-30 $0.10B 0 0.00%
2020-06-30 $0.11B $-0.00B -0.95%
2020-03-31 $0.11B $-0.00B -1.79%
2019-12-31 $0.12B $0.00B 0.86%
2019-09-30 $0.12B $0.00B 0.84%
2019-06-30 $0.12B $0.00B 2.48%
2019-03-31 $0.12B $0.00B 2.44%
2018-12-31 $0.12B $0.00B 1.64%
2018-09-30 $0.11B 0 0.00%
2018-06-30 $0.10B $-0.00B -1.00%
2018-03-31 $0.09B $-0.00B -1.15%
2017-12-31 $0.08B 0 0.00%
2017-09-30 $0.08B $-0.00B -1.22%
2017-06-30 $0.09B $-0.00B -2.27%
2017-03-31 $0.10B $-0.00B -3.16%
2016-12-31 $0.10B $-0.00B -2.88%
2016-09-30 $0.11B $-0.00B -1.89%
2016-06-30 $0.11B $-0.00B -1.87%
2016-03-31 $0.11B $-0.00B -0.91%
2015-12-31 $0.11B $-0.00B -1.83%
2015-09-30 $0.11B 0 0.00%
2015-06-30 $0.11B $0.00B 1.82%
2015-03-31 $0.11B $0.00B 3.70%
2014-12-31 $0.11B $0.01B 5.56%
2014-09-30 $0.11B $0.00B 2.83%
2014-06-30 $0.11B $0.00B 1.89%
2014-03-31 $0.11B $0.00B 0.95%
2013-12-31 $0.11B $0.00B 0.95%
2013-09-30 $0.11B $0.01B 6.67%
2013-06-30 $0.11B $0.01B 6.60%
2013-03-31 $0.11B $0.01B 6.48%
2012-12-31 $0.11B $0.01B 6.36%
2012-09-30 $0.11B $0.01B 5.41%
2012-06-30 $0.11B $0.01B 5.41%
2012-03-31 $0.11B $0.01B 7.27%
2011-12-31 $0.11B $0.01B 8.33%
2011-09-30 $0.11B $0.01B 7.34%
2011-06-30 $0.11B $0.01B 9.17%
2011-03-31 $0.11B $0.01B 8.33%
2010-12-31 $0.11B $0.01B 9.26%
2010-09-30 $0.11B $0.01B 9.43%
2010-06-30 $0.10B $0.01B 9.90%
2010-03-31 $0.09B $0.01B 9.68%
2009-12-31 $0.09B $0.01B 9.30%
Sector Industry Market Cap Revenue
Computer and Technology Scientific Instruments Manufacturing $0.167B $0.112B
HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories.
Stock Name Country Market Cap PE Ratio
Mettler-Toledo (MTD) United States $26.777B 32.88
Bruker (BRKR) United States $10.180B 28.36
Kewaunee Scientific (KEQU) United States $0.100B 11.81